首页> 外文期刊>Artificial cells, nanomedicine, and biotechnology. >Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy
【24h】

Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy

机译:联合疗法用于牛皮癣局部治疗的纳米载体的开发和表征

获取原文
           

摘要

Psoriasis is an autoimmune, chronic, inflammatory skin disease characterized by epidermal hyperplasia, proliferation of blood vessels, and infiltration of leukocytes in dermis and epidermis. Several immunosuppressants such as methotrexate (MXT) and cyclosporine are used but they are associated with adverse effects due to down regulation of immune system. Numerous approaches have been explored to overcome the problems of conventional topical system such as high frequency of application, impermeability to skin barrier, and limited efficacy. Photodynamic therapy is another non-invasive technique currently used for skin diseases. The combination of two drugs is also commonly observed to achieve more effective therapy. In the present study, antipsoriatic activity of niosomal formulations for the treatment of psoriasis in combination with narrow and broad band UV radiation had been explored in experimental animal model.
机译:牛皮癣是一种自身免疫性的慢性炎症性皮肤病,其特征在于表皮增生,血管增生以及真皮和表皮中白细胞浸润。使用了几种免疫抑制剂,例如甲氨蝶呤(MXT)和环孢霉素,但由于免疫系统的下调,它们与不良反应有关。已经探索了许多方法来克服常规局部系统的问题,例如应用频率高,对皮肤屏障的不渗透性和有限的功效。光动力疗法是当前用于皮肤疾病的另一种非侵入性技术。通常还观察到两种药物的组合可获得更有效的治疗。在本研究中,已经在实验动物模型中探索了用于配合牛皮癣的窄带和宽带紫外线辐射的尼古洛酮制剂的抗银屑病活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号